UNSPSC 51385604: Detanosal

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H19NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y09NU9DS9B, chemically known as salicylic acid, 2-(diethylamino)ethyl ester but generally known as detanosal, which bears US NIH Compound Identifier 160413. European Medicines Agency schedules Detanosal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07009MIG. The term DETANOSAL is an International Non-Proprietary Name.

UNSPSC 51385604 Detanosal, a Commodity code, represents pharmaceutical products state and local governments procure to support opioid-overdose response and harm-reduction programs. Based on recent solicitations, the code encompasses naloxone (an opioid antagonist) and safe drug deactivation systems supplied in bulk quantities with recurring annual delivery schedules. Issuing bodies under this code include county health departments and community health agencies conducting competitive bidding for stock replenishment to support emergency response and public-health initiatives.

Seminole County, Florida posted an IFB on June 30, 2026 (response due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract structure includes a two-year initial term with one-year renewal option, drug-free workplace and E-Verify compliance, and potential FEMA funding with associated federal compliance obligations. Geographic activity is limited to the single Florida jurisdiction represented in recent postings; the source does not support a broader multi-state characterization of procurement activity under this code.